生物製剂市场 - 全球产业规模、份额、趋势、机会和预测，按产品（植物、微生物、其他）、按应用（水果和蔬菜、谷物和谷类、其他）、按地区和竞争细分，2020-2030 年预测

2024年，生物农药市场价值为14.9亿美元，预计到2030年将达到24.6亿美元，复合年增长率为8.75%。全球生物农药市场正在经历快速转型，从一个专业化的利基市场发展成为作物保护产业中一个具有战略意义的重要领域。这项转变的驱动力在于，在应对农药抗药性、环境恶化和食品安全法规日益严格的关键挑战的压力日益增大的同时，对可持续、无残留农业投入品的需求也在不断增长。

生物合理性产品（包括生物农药、微生物製剂、植物製剂、昆虫生长调节剂和植物健康促进剂）因其精准的靶向作用、合规优势和良好的环境特性而日益受到重视。其低毒性和生物降解性使其非常适合融入有机农业和病虫害综合治理 (IPM) 方案，尤其适用于水果、蔬菜和出口导向农产品等高价值作物领域。

随着主要市场的监管机构逐步淘汰危险化学品投入，以及全球农业企业转向更绿色的解决方案，生物合理性正成为前瞻性作物生产策略的重要工具。它们的应用不再局限于有机农场；相反，它们正被纳入到传统的农业经营中，以提升永续资格并满足市场准入要求。

关键市场驱动因素

有机和特色作物种植快速成长

主要市场挑战

农民意识和技术知识有限

主要市场趋势

数位农业与生物合理应用的融合

这一趋势显着提高了产品性能、农民信任和投资回报率，使生物合理性更具可扩展性，更适合大规模商业农业。

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：生物合理性市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（植物、微生物、其他）
  • 依用途（水果和蔬菜、谷物和谷类、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美生物製药市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生物製药市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太生物製品市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲生物製品市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲生物製药市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球生物合理性市场：SWOT 分析

第 14 章：竞争格局

• BASF SE
• Bayer Cropscience AG
• Valent Biosciences Corporation
• Certis LLC
• UPL Limited
• Koppert BV
• Isagro SPA
• Gowan Company LLC.
• Summit Chemicals Company
• The Wonderful Company LLC.

第 15 章：策略建议

第16章调查会社について・免责事项

The Biorationals market was valued at USD 1.49 Billion in 2024 and is expected to reach USD 2.46 Billion by 2030 with a CAGR of 8.75%. The global biorationals market is undergoing a rapid transformation, evolving from a specialized niche into a strategically vital segment of the crop protection industry. This shift is being driven by the escalating need for sustainable, residue-free agricultural inputs amid mounting pressure to address critical challenges such as pesticide resistance, environmental degradation, and tightening food safety regulations.

Biorationals which include biopesticides, microbials, botanicals, insect growth regulators, and plant health enhancers are gaining prominence due to their precision-targeted action, regulatory compliance advantages, and favorable environmental profiles. Their low toxicity and biodegradability make them highly suitable for integration into organic farming and IPM (Integrated Pest Management) programs, particularly in high-value crop segments such as fruits, vegetables, and export-oriented produce.

As regulatory bodies across key markets phase out hazardous chemical inputs, and global agribusinesses pivot toward greener solutions, biorationals are becoming essential tools in forward-looking crop production strategies. Their adoption is no longer limited to organic farms; instead, they are now being incorporated into conventional operations seeking to enhance sustainability credentials and meet market access requirements.

Key Market Drivers

Rapid Growth of Organic and Specialty Crop Farming

The rapid growth of organic and specialty crop farming is a powerful catalyst driving the expansion of the global biorationals market. As the agricultural sector undergoes a paradigm shift toward more sustainable and value-driven practices, organic and high-value specialty crops are increasingly adopting biorational solutions to meet both agronomic and regulatory demands. This trend not only fuels demand but also reshapes product innovation, distribution strategies, and long-term market potential. Organic farming systems prohibit the use of synthetic pesticides and fertilizers, placing a strong emphasis on natural and environmentally friendly crop protection products. Biorationals including biopesticides, botanicals, microbials, and plant growth regulators are often certified for organic use and meet the strict criteria of organic certification bodies such as: USDA Organic (United States), EU Organic Certification (Europe), NPOP (India), IFOAM and JAS standards (global). As the organic farming industry expands, these certified biorationals become indispensable for maintaining crop health while staying compliant with organic protocols, thereby driving consistent demand.

Rising health consciousness, In 2023, the United States reported the highest gross adjusted household disposable income per capita among all OECD member nations, reflecting its strong consumer purchasing power. With an average disposable income of $62,722 per person, the U.S. led globally in personal income levels, highlighting the country's robust economic environment and elevated standard of living relative to other developed economies. This trend is especially pronounced in developed markets such as North America and Europe, but is rapidly gaining momentum in Asia Pacific, Latin America, and the Middle East. As retailers and exporters strive to offer clean-label, chemical-residue-free produce, farmers are under pressure to eliminate synthetic inputs. Biorationals offer the ideal solution, enabling growers to protect yields without compromising on food safety or certification standards. This increasing consumer-to-farm pull effect significantly amplifies the demand for biorational products.

Specialty crops such as fruits, vegetables, herbs, spices, tea, coffee, and floriculture products have high market value and low tolerance for pesticide residues. These crops are often grown under intensive conditions and are more vulnerable to pest and disease pressures. Even minimal contamination can lead to market rejections or price penalties, especially in export-driven economies. As a result, growers are more willing to invest in safer, residue-free protection solutions like biorationals to safeguard both quality and compliance. The high return on investment (ROI) for specialty crops reinforces the commercial attractiveness of adopting premium crop protection inputs. Many countries such as India, Mexico, Turkey, Kenya, and Vietnam are heavily reliant on the export of organic and specialty crops. These markets are governed by strict international regulations on Maximum Residue Limits (MRLs), particularly in regions such as the European Union, Japan, and the United States. Biorationals, due to their rapid degradation, non-toxic profiles, and low residue levels, help exporters meet stringent phytosanitary and safety requirements. This positions biorationals as essential tools not just for yield protection, but also for market access and compliance assurance. Exporters view biorationals as risk-mitigating assets in safeguarding trade relationships and maximizing export revenue.

Key Market Challenges

Limited Farmer Awareness and Technical Know-How

One of the most significant challenges hindering the widespread adoption of biorationals is the low level of awareness and understanding among farmers, particularly in emerging economies. Unlike conventional agrochemicals, biorational products often require a different approach in terms of application timing, dosage, and pest monitoring.

Lack of training and extension services results in improper use or underutilization, leading to inconsistent performance and reduced confidence among end users. Many small and medium-scale farmers are not familiar with integrated pest management (IPM) strategies where biorationals are most effective, making them reluctant to switch from familiar chemical pesticides. The absence of structured education programs, demonstration plots, and hands-on training further restricts product adoption, especially in rural areas. This knowledge gap slows market growth despite increasing availability of products.

Key Market Trends

Convergence of Digital Agriculture with Biorational Applications

A key trend driving future growth is the integration of digital technologies with biorational product usage, enhancing precision, efficiency, and data-driven decision-making in modern agriculture.

Smart farming platforms, powered by AI, IoT, and satellite imagery, are increasingly being used to monitor crop health, pest patterns, and soil conditions. These tools allow for timely and targeted application of biorational inputs, optimizing effectiveness and reducing waste. Biorational manufacturers are now collaborating with Agri-tech firms to develop digital advisory tools that recommend crop-specific biological solutions, dosage rates, and application schedules. Precision application technologies such as drones and autonomous sprayers are being adapted for the safe and uniform delivery of sensitive biologicals across large farms.

This trend is significantly improving product performance, farmer trust, and return on investment making biorationals more scalable and viable for large-scale commercial agriculture.

Key Market Players

• BASF SE
• Bayer Cropscience AG
• Valent Biosciences Corporation
• Certis LLC
• UPL Limited
• Koppert B.V.
• Isagro S.P.A.
• Gowan Company LLC.
• Summit Chemicals Company
• The Wonderful Company LLC.

Report Scope:

In this report, the Global Biorationals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biorationals Market, By Product:

• Botanical
• Microbial
• Others

Biorationals Market, By Application:

• Fruits & Vegetables
• Grains & Cereals
• Others

Biorationals Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biorationals Market.

Available Customizations:

Global Biorationals market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Biorationals Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Botanical, Microbial, Others)
  • 5.2.2. By Application (Fruits & Vegetables, Grains & Cereals, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biorationals Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biorationals Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Biorationals Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Biorationals Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Biorationals Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biorationals Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Biorationals Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Biorationals Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. France Biorationals Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Biorationals Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Biorationals Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biorationals Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Biorationals Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Biorationals Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Biorationals Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Biorationals Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Biorationals Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biorationals Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Biorationals Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Biorationals Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Biorationals Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biorationals Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Biorationals Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Biorationals Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Biorationals Market: SWOT Analysis

14. Competitive Landscape

• 14.1. BASF SE
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Bayer Cropscience AG
• 14.3. Valent Biosciences Corporation
• 14.4. Certis LLC
• 14.5. UPL Limited
• 14.6. Koppert B.V.
• 14.7. Isagro S.P.A.
• 14.8. Gowan Company LLC.
• 14.9. Summit Chemicals Company
• 14.10.The Wonderful Company LLC.

15. Strategic Recommendations

16. About Us & Disclaimer